Follow
Sedana Medical AB
Nasdaq First North Sweden (Sweden)
Sedana Medical AB is a Sweden based medical technology company. It's Anaesthetic Conserving Device (AnaConDa) is an anaesthetic delivery system developed for the administration of volatile anaesthetics such as isoflurane or sevoflurane to invasively ventilated patients. AnaConDa is a small device that is inserted in the breathing circuit between the ET-Tube and the Y-piece. The product range of the group is AnaConDa, AnaConDa-S, AnaConDa syringe, FlurAbsorb-S, FlurAbsorb accessory kit, Nafion line, and othe Sedana Medical AB is a Sweden based medical technology company. It's Anaesthetic Conserving Device (AnaConDa) is an anaesthetic delivery system developed for the administration of volatile anaesthetics such as isoflurane or sevoflurane to invasively ventilated patients. AnaConDa is a small device that is inserted in the breathing circuit between the ET-Tube and the Y-piece. The product range of the group is AnaConDa, AnaConDa-S, AnaConDa syringe, FlurAbsorb-S, FlurAbsorb accessory kit, Nafion line, and others. The company operates in Sweden, Germany, Spain, Ireland, and France, out of which Germany accounts for the majority of the revenue.

Read more

Sector:
HEALTH CARE
>
Medical Instruments & Supplies
Media
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
SEDANA
SE0009947534
Nasdaq First North Sweden
Sweden (SE)
Details of share in Sedana Medical AB with ticker SEDANA
Status
Active
Order book id
Amount of instruments
23 046 740
Par value
0.1000
Market cap
Currency
SEK
Segment
First North
First trading date
21 Jun 2017
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
19.50 SEK
206M SEK
08 Jun - 16 Jun 2017
IPO in Sedana Medical AB
Market
Nasdaq First North Sweden
Subscription period
08 Jun - 16 Jun 2017
Subscription price
19.50 SEK
Price per share
19.50 SEK
Target to raise
115 000 000 SEK
Types
Share issue
Pre-money valuation
206 000 000 SEK
Subscription block size
10
Minimum subscription
500
Record date
Offer status
Closed
Listing status
Listed
First trading date
21 Jun 2017
Issue terms
Open to the public.
Comments for offer & related information
The Offering comprises 5,128,205 new shares. Anchor investors (HealthInvest Partners AB, Alto Invest SA, Brohuvudet AB, Nyenburgh Holding BV, Alfred Berg Kapitalförvaltning AB) subscribe a total of SEK 55 million.
Type
Price
Pre-money valuation
Time
Files
New issue
65.00 SEK
04 Jun - 05 Jun 2018
Share issue in Sedana Medical AB
Market
Nasdaq First North Sweden
Subscription period
04 Jun - 05 Jun 2018
Subscription price
Price per share
65.00 SEK
Target to raise
112 000 000 SEK
Types
Share issue
Pre-money valuation
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Directed new share issue to Swedish and international investors organised by Pareto Securities AB.
Comments for offer & related information
The subscription price and the total number of new shares in the Private Placement will be determined through an accelerated bookbuilding procedure (the “Bookbuilding”). The number of new shares will not exceed 10 percent of the number oustanding of shares in the Company (i.e. not exceed 1,728,053 shares). The Bookbuilding will start no earlier than 17:31 CET 4 June 2018. Pricing and allocation of the new shares is expected to take place before beginning of trading on Nasdaq First North Stockholm at 09:00 CET on 5 June 2018. The timing of the closing of the Bookbuilding, pricing and allocations are at the discretion of the Company and Pareto Securities. The Company will announce the outcome of the Private Placement after closing of the Bookbuilding in a subsequent press release.
Result of offer
The Company has successfully completed a directed new share issue of approximately SEK 112 million.
Type
Price
Pre-money valuation
Time
Files
New issue
129.50 SEK
09 Oct - 10 Oct 2019
Share issue in Sedana Medical AB
Market
Nasdaq First North Sweden
Subscription period
09 Oct - 10 Oct 2019
Subscription price
Price per share
129.50 SEK
Target to raise
350 000 000 SEK
Types
Share issue
Pre-money valuation
Subscription block size
Minimum subscription
Record date
Offer status
Closed
Listing status
Listed
Issue terms
Directed new share issue to Swedish and international investors organised by Pareto Securities AB.
Comments for offer & related information
The issue was announced after the stock exchange closed on 9 October 2019 and should be completed before the stock exchange opens on 10 October 2019.

Result of offer
Sedana Medical AB has completed a directed new share issue of 2,896,000 shares, raising proceeds of SEK 375 million.
Type
Price
Pre-money valuation
Time
Files
Market move
2021
Listing of Sedana Medical AB on NASDAQ STOCKHOLM
Move from
Nasdaq First North Sweden
Move to
NASDAQ STOCKHOLM
Status
Upcoming
Comments for listing & related information
The board of directors of Sedana Medical AB (publ) (“Sedana Medical” or the “Company”) has resolved to evaluate the possibilities of listing the Company’s shares on Nasdaq Stockholm’s main market within 18 months.
Documents
People
Number of Employees
46 people
Sven Christer Ahlberg
CEO
Thomas Eklund
Chairman of the board
Thomas Eklund
Board member
Sten Gibeck
Board member
Bengt Julander
Board member
Ola Magnusson
Board member
Michael Ryan
Board member
Company Details
Sector
HEALTH CARE

Address
Vendevägen 87 5tr
Zip code
182 32
City/district
Danderyd
Country
Sweden (SE)
Registration number
556670-2519
LEI code
549300FQ3NJRI56LCX32
First trade date
21 Jun 2017
Registration date
11 Nov 2004
Short name
Sedana Medical

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date